AU555961B2 - 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas - Google Patents

1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas

Info

Publication number
AU555961B2
AU555961B2 AU12167/83A AU1216783A AU555961B2 AU 555961 B2 AU555961 B2 AU 555961B2 AU 12167/83 A AU12167/83 A AU 12167/83A AU 1216783 A AU1216783 A AU 1216783A AU 555961 B2 AU555961 B2 AU 555961B2
Authority
AU
Australia
Prior art keywords
diethylureas
ergolinyl
8alpha
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU12167/83A
Other languages
English (en)
Other versions
AU1216783A (en
Inventor
Antonin Cerny
Jiri Krepelka
Karel Rezabek
Miroslav Seda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Original Assignee
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Spojene Podniky Pro Zdravotnickou Vyrobu, Spofa Vereinigte Pharma Werke filed Critical Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Publication of AU1216783A publication Critical patent/AU1216783A/en
Application granted granted Critical
Publication of AU555961B2 publication Critical patent/AU555961B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12167/83A 1982-03-12 1983-03-08 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas Ceased AU555961B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS821734A CS231214B1 (en) 1982-03-12 1982-03-12 Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea

Publications (2)

Publication Number Publication Date
AU1216783A AU1216783A (en) 1983-09-15
AU555961B2 true AU555961B2 (en) 1986-10-16

Family

ID=5352449

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12167/83A Ceased AU555961B2 (en) 1982-03-12 1983-03-08 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas

Country Status (15)

Country Link
JP (1) JPS58180484A (da)
AT (1) AT383349B (da)
AU (1) AU555961B2 (da)
BE (1) BE896122A (da)
CA (1) CA1203531A (da)
CH (1) CH652125A5 (da)
CS (1) CS231214B1 (da)
DE (1) DE3308719A1 (da)
DK (1) DK84683A (da)
FI (1) FI830754A7 (da)
FR (1) FR2523131B1 (da)
GB (1) GB2116548B (da)
IT (1) IT1161209B (da)
NL (1) NL8300829A (da)
SE (1) SE452321B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
FR2584720B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation de derives n-methyles de l'ergoline
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
DE3623503A1 (de) * 1986-07-09 1988-01-21 Schering Ag 1-aryl-ergolinyl-harnstoffderivate, verfahren zu deren herstellung sowie die verwendung dieser verbindungen als arzneimittel
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
EP2637644A1 (de) * 2010-11-11 2013-09-18 Sinoxa Pharma UG Lisurid, tergurid und derivate davon zur verwendung in der prophylaxe und/oder therapie fibrotischer veränderungen
BR112017015510A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2020522504A (ja) 2017-06-01 2020-07-30 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ 多環式化合物およびそれらの用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
AT231082B (de) * 1960-10-12 1964-01-10 Sandoz Ag Verfahren zur Herstellung von neuen Harnstoff-Derivaten
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
SE8301257D0 (sv) 1983-03-08
FI830754L (fi) 1983-09-13
AU1216783A (en) 1983-09-15
FR2523131A1 (fr) 1983-09-16
CH652125A5 (de) 1985-10-31
DK84683A (da) 1983-09-13
SE452321B (sv) 1987-11-23
GB8305735D0 (en) 1983-04-07
DE3308719A1 (de) 1983-09-22
ATA72783A (de) 1986-11-15
SE8301257L (sv) 1983-09-13
IT8319935A0 (it) 1983-03-07
BE896122A (fr) 1983-07-01
FI830754A0 (fi) 1983-03-07
CS231214B1 (en) 1984-10-15
CA1203531A (en) 1986-04-22
IT1161209B (it) 1987-03-18
FR2523131B1 (fr) 1987-08-28
FI830754A7 (fi) 1983-09-13
GB2116548B (en) 1985-03-20
AT383349B (de) 1987-06-25
GB2116548A (en) 1983-09-28
NL8300829A (nl) 1983-10-03
DK84683D0 (da) 1983-02-24
JPS58180484A (ja) 1983-10-21

Similar Documents

Publication Publication Date Title
AU1216783A (en) 1-substituted n-(8alpha-ergolinyl)-n:,n:-diethylureas
AU2410284A (en) Capstanspil, navnlig til sejlbade
AU1270583A (en) 3-azolyl-1,2-diaryl-1-halogenoprop-1-enes
AU565667B2 (en) N, n-di-n-propyl-4-hydroxy-3- methanesulphonamidophenethylamine
AU561449B2 (en) Pharmaceutical 3-aryl-7-chloro-9-oxo-3,4-dihyroacridines
AU561832B2 (en) 1-(alkyl-phenoxyaryl)-3-benzoyl ureas
AU1792983A (en) 2,3-dihydrobenzofurans
AU553831B2 (en) N,n-disubstituted azolecarboxamides
AU1505783A (en) Spanner
AU562725B2 (en) 16-fluoro-16, 17-didehydro-prostanoids
AU563881B2 (en) Carbacycline, preparation and utilization thereof
AU563276B2 (en) 1 - substituted azacycloalkan - z ones
AU540498B2 (en) N-substituted 2-amino-3,4-dihydro-pyridives
PH20015A (en) N-(1-(4-amino-6,7-dialkoxy-2-quinazolinyl)-4-piperidyl)-oxazolidine-2,4-diones
AU1734183A (en) 3alpha-(substituted-phenyl)-3alpah,4,7,7alpha-tetrahydro-4, 7-methanoisoindolines
AU554684B2 (en) N-(2-methyl-5-chlorophenyl)-n-methoxyacetyl-3-amino- 1,3-oxazolydin-2-one
AU551883B2 (en) 2,5-bis-perfluoroalkyl-3,4-dicarbonylalkoxypyrroles
AU563809B2 (en) 3-acyl-2-nitromethylene-tetrahydro-2h-1,3-thiazines
AU568648B2 (en) 1,2,3-thiazole-3-in-5-ylidine ureas
AU1176983A (en) 2,3-dihydro-1h-pyrrolizines
AU572822B2 (en) N,n-diethyl-ergolin-8-yl-sulphamide
AU6657581A (en) N-(tetrahydro-2-oxo-3-furyl)-2:,6:acetoxylidide
AU1340183A (en) Alpha-halo-n,n-dimethylpropionamides
AU2036683A (en) Ammonia scavenger
AU546925B2 (en) 3-acetyl-4-oxo-2,2-azetidine-dicarboxylate derivatives